Extent of lymphadenectomy and outcome for patients with stage i nonsmall cell lung cancer

Cancer

Volumn 115, Issue 4, 2009, Pages 851-858

  Varlotto, John M ^a,c   Recht, Abram ^a   Nikolov, Margaret ^a   Flickinger, John C ^b   Decamp, Malcolm M ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Lymph nodes; Lymphadenectomy; Mediastinal dissection; Nonsmall cell carcinoma

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; DATA BASE; DIAGNOSTIC ACCURACY; DISEASE FREE SURVIVAL; EPIDEMIOLOGICAL DATA; FEMALE; FOLLOW UP; HUMAN; LUNG SMALL CELL CANCER; LYMPH NODE; LYMPH NODE DISSECTION; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; NONSMALL CELL LUNG CANCER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POPULATION; PRIORITY JOURNAL;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SEER PROGRAM; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 60849135122     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23985     Document Type: Article

References (27)

1. Doddoli C, Aragon A, Barlesi F, et al. Does the extent of lymph node dissection influence outcome in patients with stage I non-small cell lung cancer? Eur J Cardiothorac Surg. 2005;27:680-685.
2. Keller SM, Adak S, Wagner H, et al. Mediastinal lymph node dissection improves survival in patients with stages II and IIIA non-small cell lung cancer. Ann Thorac Surg. 2000;70:358-366.
3. Lardinois D, Suter H, Hakki H, et al. Morbidity, survival, and site of recurrence after mediastinal lymph node dissection versus systematic sampling after complete resection for non-small cell lung cancer. Ann Thorac Surg. 2005;80:268-275.
4. Rami-Porta R, Wittekind C, Goldstraw P. Complete resection in lung cancer surgery: proposed definition. Lung Cancer. 2005;49:25-33.
5. Gajra A, Newman N, Gamble G, et al. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small cell lung cancer. J Clin Oncol. 2003;21:1029-1034.
6. Funatsu T, Matsubara Y, Ikeda S, et al. Pre-operative mediastinoscopic assessment of N factors and the need for mediastinal node dissection in T1 lung cancer. J Thorac Cardiovasc Surg. 1994;108:321-328.
7. Nakahara K, Fujii Y, Matsumura A. Role of systemic mediastinal dissection in N2 non-small cell lung cancer patients. Ann Thorac Surg. 1993;56:331-336.
8. Ginsberg RJ. Lymph node involvement, recurrence and prognosis in resected small, peripheral, non-small cell lung carcinomas [editorial]. J Thorac Cardiovasc Surg. 1996;111:1123-1124.
9. Wu Y, Huang Z, Wang S. A randomized trial of systemic nodal dissection in resectable non-small cell lung cancer. LungCancer. 2002;36:1-6.
10. Sugi K, Nawata K, Fujita N, et al. Systematic lymph node dissection for clinically diagnosed peripheral non-small cell lung cancer less than 2 cm in diameter. World J Surg. 1998;22:290-295.
11. Izbicki JR, Passlick B, Pantel K, et al. Effectiveness of radical systemic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer. Ann Surg. 1998;227:138-144.
12. Surveillance, Epidemiology, and End Results (SEER) Program Public-Use Data (1973-2003), National Cancer Institute, DCCPS, Surveillance Research Statistics Branch. Available at: http://seer.cancer.gov/publicdata/ Accessed May 3, 2006.
13. Surveillance, Epidemiology and End Results (SEER) Program. Data quality. Available at: http://seer.cancer.gov/about/quality.html Accessed May 3, 2006.
14. Leong SS, Rocha Lima CM, Sherman CA, Green MR. The 1997 International Staging System for non-small cell lung cancer: have all the issues been addressed? Chest. 1999;115:242-248.
15. Kaplan ES, Meier P. Non-parametric estimation from incomplete observation. Am Stat Assoc. 1958;53:475-480.
16. Mantel N. Evaluation of survival data and 2 new rank order statistics arising in its consideration. Cancer Chemo- ther Rep. 1966;50:163-170.
17. Brock MV, Hooker CM, Ota-Machida E, et al. DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med. 2008;358:1118-1128.
18. Lung Cancer Study Group. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Ann Thorac Surg. 1995;60:615-623.
19. Czerny M, Fleck T, Salat A, et al. Sealing of the mediastinum with local hemostypic agent reduces chest tube duration after complete mediastinal lymph node dissection for stage I and II NSCLC. Ann Thorac Surg. 2004;77:1028-1032.
20. Ziomek S, Read RC, Tobler HG, et al. Thromboembolism in patients undergoing thoracotomy. Ann Thorac Surg. 1993;56:223-226.
21. Manser R, Wright G, Hart D, et al. Surgery for early stage non-small cell lung cancer. Cochrane Libr. 2006;2:1-39.
22. Oda M, Watanabe Y, Shimizu J, et al. Extent of mediastinal node metastasis node metastasis in clinical stage I non-small cell lung cancer: the role of systemic nodal dissection. Lung Cancer. 1998;22:23-30.
23. Passlick B, Kubuschock B, Sienel W, et al. Mediastinal lymphadenectomy in non-small cell lung cancer: effectiveness in patients with or without nodal micrometastases results of a preliminary study. Eur J Cardiothorac Surg. 2002;21:520-526.
24. Landinois D, Brack T, Gaspert A, et al. Bronchoscopic radio-isotope injection for sentinel lymph-node mapping in potentially resectable non-small cell lung cancer. Eur J Cardiothorac Surg. 2003;23:824-827.
25. Wu J, Ohta Y, Minato H, et al. Nodal occult metastasis in patients with peripheral lung adenocarcinoma of 2.0 cm or less in diameter. Ann Thorac Surg. 2001;71:1772-1778.
26. Asamura H, Nakayama H, Kondo H, et al. Lobe-specific extent of systemic lymph node dissection for non-small cell carcinomas according to a retrospective study of metastasis and prognosis. J Thorac Cardiovasc Surg. 1999;117:1102-1111.
27. DeGiacomo T, Venuta F, Rendina EA. Role of lymphadenectomy in the treatment of clinical stage I non-small cell lung cancer. Thorac Surg Clin. 2007;17:217-221.